EP0439442A2
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Factor x-laci hybrid protein
Assignee: University of Washington
•
Filing: 1991-01-21
•
Granted: —
•
Expires: 2011-01-21
Abstract
Abstract A single-chain hybrid blood coagulation inhibitor is disclosed which has an amino acid sequence composed of two subsequences corresponding to the light chain of Factor X and LACI's first Kunitz domain. <IMAGE>
Inventors
- 👤 Thomas James Girard
- 👤 George John Broze Jr.
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-10-25 09:43
CPC Classifications
C; C12; C12N; C12N9/00; C12N9/14; C12N9/48; C12N9/50; C12N9/64; C12N9/6421; C12N9/6424; C12N9/6432; A; A61; A61P; A61P7/00; A61P7/02; C07; C07K; C07K14/00; C07K14/81; C07K14/8107; C07K14/811; C07K14/8114; C12Y; C12Y304/00; C12Y304/21; C12Y304/21006; A61K; A61K38/00; C07K2319/00; C07K2319/01; C07K2319/02
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
26 words
A single-chain hybrid protein having an amino acid sequence composed of two subsequences corresponding to the light chain of Factor X and LACI's first Kunitz domain.
Claim 2
Dependent Claim
22 words
A single-chain hybrid protein having an amino acid sequence as shown in FIG. 1 (Fig. 1A + Fig. 1B) of the drawings.
Claim 3
Dependent Claim
16 words
The single-chain hybrid protein of either Claim 1 or Claim 2 for use as a medicament.
Claim 4
Dependent Claim
18 words
The single-chain hybrid protein of either Claim 1 or Claim 2 for use as a blood coagulation inhibitor.
Claim 5
Dependent Claim
21 words
The single-chain hybrid protein of either Claim 1 or Claim 2 for use as a blood coagulation inhibitor in a mammal.
Claim 6
Dependent Claim
30 words
Use of a single-chain hybrid protein according to either Claim 1 or Claim 2 for the manufacture of a medicament for use as a blood coagulation inhibitor in a mammal.
Claim 7
Dependent Claim
13 words
A DNA sequence comprising a sequence encoding the hybrid protein of Claim 1.
Claim 8
Dependent Claim
13 words
A DNA sequence comprising a sequence encoding the hybrid protein of Claim 2.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.